Skip to main content
Premium Trial:

Request an Annual Quote

NIH Calls for Input on Prioritizing Development of Affinity Reagents to Transcription Factors

Premium

The National Institutes of Health this week put out a call for input on a priority list for renewable affinity reagents for human transcription factors.

The outreach is part of the NIIH's Protein Capture Reagents Program, which is intended to determine if a source of high-quality, renewable affinity reagents can be generated and validated for all human proteins and to build technologies for doing so.

As a test case, the program seeks to generate affinity reagents against all human transcription factors.

The program's Target List working group has identified a list of targets to begin production of affinity reagents against and is now seeking input from researchers about the list and assistance in validation of these reagents for a variety of applications and CHiP-seq in particular.

Comments can be contributed through Oct. 31, and can be made here.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.